|
MTA2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.54719999999809E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.23449999999992E-05 |
| Normal-vs-Stage2 |
7.050100E-02 |
| Normal-vs-Stage3 |
3.495300E-03 |
| Normal-vs-Stage4 |
3.196200E-04 |
| Stage1-vs-Stage2 |
3.089800E-01 |
| Stage1-vs-Stage3 |
3.999600E-01 |
| Stage1-vs-Stage4 |
5.103800E-01 |
| Stage2-vs-Stage3 |
7.073200E-01 |
| Stage2-vs-Stage4 |
2.067600E-01 |
| Stage3-vs-Stage4 |
2.221200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.200750E-04 |
| Normal-vs-AfricanAmerican |
2.400100E-04 |
| Normal-vs-Asian |
1.795530E-02 |
| Caucasian-vs-AfricanAmerican |
5.124500E-02 |
| Caucasian-vs-Asian |
4.187200E-01 |
| AfricanAmerican-vs-Asian |
9.888600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.217800E-04 |
| Normal-vs-Female |
1.05470000000274E-06 |
| Male-vs-Female |
2.511800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.496000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.03169999999364E-05 |
| Normal-vs-Age(61-80Yrs) |
3.376100E-04 |
| Normal-vs-Age(81-100Yrs) |
1.938820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.173400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.380600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.560800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.217000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.961800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.990600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.000300E-03 |
| Normal-vs-Grade 2 |
1.176770E-04 |
| Normal-vs-Grade 3 |
7.999500E-03 |
| Normal-vs-Grade 4 |
4.47049999999782E-05 |
| Grade 1-vs-Grade 2 |
8.683500E-03 |
| Grade 1-vs-Grade 3 |
8.381500E-04 |
| Grade 1-vs-Grade 4 |
1.040600E-01 |
| Grade 2-vs-Grade 3 |
1.728030E-01 |
| Grade 2-vs-Grade 4 |
1.288410E-01 |
| Grade 3-vs-Grade 4 |
2.014300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.901510E-03 |
| Normal-vs-ccB subtype |
3.782000E-04 |
| ccA subtype-vs-ccB subtype |
4.753600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.043310E-03 |
| Normal-vs-N1 |
1.181830E-01 |
| N0-vs-N1 |
6.764400E-01 |
|
|
